Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Sector ETF Winners Of Bull Market Look Resilient To Virus

Published 03/10/2020, 01:30 AM
Updated 07/09/2023, 06:31 AM

The bull market turned 11 yesterday. The collapse of Lehman Brothers in September 2008 wreaked havoc on Wall Street. And on Mar 9, 2009, the S&P 500 bottomed out to start an astral rally. But all this is history today as the S&P 500 is now trading at 2,746.56 (as of Mar 9, 2020). The Fed’s quantitative easing and rock-bottom interest rate policy in order to boost a struggling economy took Wall Street to this high.

However, it seems that the bull market won’t last long as the coronavirus outbreak appears to be as big a threat as the 2008 financial crisis. The S&P 500 is now down 19.1% from its all-time high of 3393.52. If the decline continues, with the S&P 500 20% below its record high, the bull market that began in March 2009 will officially be over.

On Mar 9, 2020, the blue-chip Dow Jones suffered its largest points single-day drop ever (down 7.8%), with the S&P 500 (down 7.6%) and the Nasdaq (down 7.8%) seeing one of the worst days since the financial crisis. Crude oil prices plunged 25% after the world's key producing countries failed to cut an output cut deal. All these sparked severe global growth crisis, dealing a big blow to the market.

Let’s take a look at the sector ETF winners of the past decade and if these can continue to soar irrespective of the coronavirus attack.

Sector ETF Winners

Technology

The emergence of cutting-edge technology, such as cloud computing, big data, IoT, virtual reality devices and AI as well as strong corporate earnings, is driving the sector.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Though the tech space is also in the red amid the current virus-induced selloff, it should be resilient to steep selloffs as the space involves less human contact. Tech companies, especially those involved in Internet and cloud-related businesses, should stay afloat. If the virus spreads, “cloud software is going to become essential, with an increasing amount of people working from home” (read: Amid the Tech Slump, Internet ETFs Most Resilient to Virus).

First Trust Dow Jones Internet ETF FDN – Up about 888.9% in the past 11 years

First Trust NASDAQ-100-Tech Sector ETF QTEC – Up about 789.4%

Biotech

Successful clinical trials for new drugs, a flurry of FDA approvals, higher demand from emerging markets, and ramped-up merger and acquisition hold the key to the sector’s success in recent times. The emergence of the novel coronavirus has enhanced the sector’s appeal even more as its players are now busy formulating a breakthrough vaccine for it (read: Can Biotech ETFs Gain on Mixed Q4 Earnings Results?).

First Trust NYSE Arca Biotech ETF FBT – Up about 717.6%

SPDR S&P Biotech (NYSE:XBI) ETF XBIUp about 485.2%

Consumer Discretionary

After years of stagnation, the U.S. job market has gathered steam, giving many lower income consumers some extra cash. The U.S. economy added 273,000 jobs in February 2020, the maximum since May 2018, compared to an upwardly revised 273 thousand in January and market expectations of 175,000. Low fuel prices over the last few years continued to fatten consumers’ wallets.

Vanguard Consumer Discretionary ETF (HN:VCR) – Up about 666.7%

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Consumer Discretionary Select Sector SPDR ETF (TSXV:XLY) – Up about 684.7%

Healthcare

This sector is a bit defensive in nature. An aging population, growing demand in emerging markets and product launches are working in favor of the sector. Also, the coronavirus scare should generate higher business for the space.

First Trust Health Care AlphaDEX ETF FXHUp about 527.1%

Invesco Dynamic Pharmaceuticals ETF (WA:PJP) – Up about 422.4%

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



Vanguard Consumer Discretionary ETF (VCR): ETF Research Reports

SPDR S&P Biotech ETF (XBI): ETF Research Reports

First Trust NYSE Arca Biotechnology ETF (FBT): ETF Research Reports

Consumer Discretionary Select Sector SPDR ETF (XLY): ETF Research Reports

Invesco Dynamic Pharmaceuticals ETF (PJP): ETF Research Reports

First Trust Dow Jones Internet ETF (FDN): ETF Research Reports

First Trust Health Care AlphaDEX ETF (FXH): ETF Research Reports

First Trust NASDAQ-100-Technology Sector ETF (QTEC): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.